News
Beyond Weight Loss: Why Doctors Are Now Prescribing GLP-1 Drugs for Heart Disease, Addiction, and Dementia Risk
51+ min ago (267+ words) Maria Delgado, a 54-year-old accountant from Phoenix, started semaglutide injections in early 2024 for one reason: her doctor wanted her to lose 40 pounds ahead" What made SELECT remarkable was who enrolled: participants did not have diabetes. The traditional assumption had been…...
Long COVID's Undefined Neurological Symptoms Leave Millions in Diagnostic Limbo, Federal Data Shows
59+ min ago (270+ words) Approximately 17.6 million American adults reported experiencing long COVID as of the most recent CDC Household Pulse Survey " yet more than four years after" The word "unspecified" inside that diagnostic code is not administrative filler. It is a direct reflection of…...
Ultra-Processed Foods Now Linked to 32 Distinct Diseases, and the Data Is Reshaping How Doctors Treat Chronic Illness
2+ hour, 59+ min ago (547+ words) The mainstream nutritional conversation has spent decades obsessing over macronutrients " fat grams, carbohydrate counts, protein targets " while systematically ignoring the variable with the" This is not a fringe finding from a small cohort. It represents the most statistically powered examination…...
GLP-1 Drug Users Are Losing Significant Muscle Mass, Not Just Fat, According to New Clinical Data
11+ hour, 56+ min ago (448+ words) The weight-loss revolution has a body composition problem that its most enthusiastic advocates have been reluctant to discuss. GLP-1 receptor agonists " sold under brand" This is not a fringe concern from skeptics. It is coming from within the research institutions…...
Beyond Weight Loss: New Clinical Data Shows GLP-1 Drugs May Guard Against Alzheimer's and Addiction
1+ hour, 57+ min ago (387+ words) The conventional wisdom that GLP-1 receptor agonists like semaglutide " sold under the brand names Ozempic and Wegovy " are obesity and diabetes medications is" No GLP-1 drug is currently approved by the U.S. Food and Drug Administration for Alzheimer's prevention or treatment....
The $50 Billion Weight Loss Drug Race Has a New Front-Runner Nobody Expected
3+ hour, 52+ min ago (261+ words) A window is closing for the pharmaceutical giants that have dominated obesity medicine for the past four years. As of April 2026, at least three" That disruption, more than any single clinical trial, accelerated the industry's push toward oral formulations. A…...
How to Build a Consistent Sleep Schedule That Genuinely Improves Your Health
21+ hour, 41+ min ago (548+ words) Roughly 70 million Americans live with a chronic sleep disorder, according to the CDC's sleep research division " and the economic damage from lost productivity" Roughly 70 million Americans live with a chronic sleep disorder, according to the CDC's sleep research division " and…...
Semaglutide's Expanded FDA Approval Opens Coverage Fight for 3.4 Million Americans With Heart Failure
2+ hour, 30+ min ago (371+ words) Maria Delgado, a 61-year-old retired schoolteacher in San Antonio, Texas, learned in February 2026 that she qualified for semaglutide under a newly expanded FDA indication" Delgado's situation is not isolated. Across the country, patients and clinicians are navigating a widening gap…...
New Genetic Research Reveals Why the 8-Hour Sleep Rule Does Not Apply to Everyone
2+ hour, 53+ min ago (334+ words) Approximately 35% of American adults regularly sleep fewer than seven hours per night, according to the CDC's Sleep and Sleep Disorders data. Public health messaging" This is not a fringe argument from sleep-hack influencers or productivity gurus. It is a position…...
Semaglutide Reduces Major Cardiac Events by 20%, New Trial Data Confirms as Insurers Weigh Coverage Mandates
10+ hour, 49+ min ago (140+ words) As of April 2026, cardiologists and federal health officials are under mounting pressure to act on accumulating evidence that semaglutide " the GLP-1 receptor agonist" UnitedHealth Group, CVS Caremark, and Cigna have each updated their formulary criteria since the FDA's cardiovascular approval,…...